Strategic Partnership Agreement between AME Publishing Company and Italian Society of Thoracic Surgery (SICT) is signed!

In this wonderful season of Spring, we would like to share with you an exciting good news—the agreement of strategic partnership between AME Publishing Company and Italian Society of Thoracic Surgery (SICT) is officially confirmed and signed!

The partnership with SICT is another big move of AME made in the thoracic surgery field. With this new progress and endeavor of both sides, we believe a bright and better future will be brought to our surgeons and more importantly, patients all around the world!

Read More>>

Join us at the AATS Centennial--Celebrating 100 Years of Modeling Excellence!

The 97th Annual Meeting of American Association for Thoracic Surgery (AATS) (AATS Centennial) is going to be held at the Boston Hynes Convention Center, Boston, USA, from April 29 to May 3, 2017.

This time, ATM as well as its sister journals and books published by AME Publishing Company will be on display during this exciting academic event! We would like to seize this great opportunity to meet our authors, editorial board members and readers. Our booth Number is 620. Look forward to your participation and meeting you onsite!

Read More>>

Welcome to the Ninth Postgraduate Course on “Surgery of The Thoracic Aorta”!

The Ninth Postgraduate Course on “Surgery of The Thoracic Aorta” is going to take place in Bologna from 13th to 14th November 2017.

This interactive meeting will focus on open, hybrid, transcatheter and endovascular techniques employed during operations on the thoracic aorta.

Read More>>

2016 Annual Report of ATM

Greetings from Profs. Jianxing He, Rafael Rosell, Xuehao Wang, and Editorial Office of ATM！

We are glad to present the 2016 Annual Report of ATM here. In 2016, ATM progressed fast and smoothly under the join-efforts of experts worldwide. The total citation number has significantly increased from 309 in January to 1294 in December. The journal was exhibited in some international meetings, to attract wider attention and exposure. More information is shown in the Annual Report.

We would like to express sincere appreciation for the enthusiastic and vigorous support and contributions from all board members, guest editors, reviewers, authors, readers, etc. We wish you a happy, healthy and prosperous 2017!      Read More>>

Red cell distribution width and cancer

The aim of this narrative review is to summarize some interesting results obtained in studies performed in patients affected by solid and hematological tumors. Even if larger studies are needed before these preliminary findings can be generalized, it seems plausible to affirm that RDW can be useful by adding prognostic information in patients with oncologic disease.

Read More>>

Review: capsule colonoscopy—a concise clinical overview of current status

The colon capsule endoscopy (CCE) was first introduced in 2007. Currently, the main clinical indications for CCE are completion of incomplete colonoscopy, polyp detection and investigation of inflammatory bowel disease (IBD). Although conventional colonoscopy is the gold standard in bowel cancer screening, incomplete colonoscopy remains a problem as lesions are missed. CCE compares favourably to computer tomography colonography (CTC) in adenoma detection and has therefore been proposed as a method for completing colonoscopy. However the data on CCE remains sparse and current evidence does not show its superiority over CTC or conventional colonoscopy in bowel cancer screening. 

Read More>>

Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola

There is an ongoing threat of epidemic or pandemic diseases that could be caused by influenza, Ebola or other emerging viruses. It will be difficult and costly to develop new drugs that target each of these viruses. Statins and angiotensin receptor blockers (ARBs) have been effective in treating patients with sepsis, pneumonia and influenza, and a statin/ARB combination appeared to dramatically reduce mortality during the recent Ebola outbreak. These drugs target (among other things) the endothelial dysfunction found in all of these diseases.

Read More>>

Clinical significance of cell population data (CPD) on Sysmex XN-9000 in septic patients with our without liver impairment

This study evaluated the clinical significance of cell population data (CPD) parameters obtained on Sysmex XN-9000 in septic patients admitted to intensive care unit (ICU) and stratified according to liver function.

Read More>>

Focus on “Innovations and Technology in Surgery” Guest Edited by Drs. Michael Sosin and Ketan M. Patel

In a two-part supplemental issue, our distinguished authors have finely reviewed topics of today and (inevitably) tomorrow. Some topics may be unfamiliar to many clinicians, which is why we specifically selected subjects that would be of interest to both physicians and surgeons.

Read More>>

What should the blood pressure treatment goal be in adults with hypertension in 2016?

On the basis of randomized clinical trial data including the Hypertension in the Very Elderly (HYVET) trial (1) and the Systolic Hypertension in the Elderly (SHEP) trial (2-4), the American College of Cardiology Foundation/ American Heart Association 2011 hypertension guidelines (5), the European Society of Hypertension/European Society of Cardiology 2013 hypertension guidelines (6), the 2014 American Society of Hypertension/International Society of Hypertension guidelines (7)...

Read More>>

The role of genetics and antibodies in sepsis

Candidate genes affecting antibody responses in sepsis.

Read More>>

Focused Issue on “Management of Infections in Septic Shock” guest edited by Drs. Jordi Rello and Hakan Erdem

This issue is a compilation of reviews done by expert opinion leaders on critical care and infectious diseases who addressed these two edges. Therefore, it covers a broad spectrum of topics, with special emphasis on issues related with management and the organism. It provides an update of first line research on their respective topics. It also provides valuable information for clinical practitioners, who has limited time to review the vast scientific production and to non-specialists that...

Read More>>

Testimonials for ATM from Eminent Experts Worldwide

In less than two months, ATM has received about 30 supporting letters from the prominent experts worldwide, who are editorial board members, authors and readers knowing ATM well. This is encouraging. We are grateful for their vigorous support to the journal.

Below abstracts some parts from their supporting letters.

Read More>>

Asian Society of Thoracic Surgery (ASTS) was officially launched: collaborate across Asia and the world 

On July 31, the 2^nd Consultative Meeting on Asian Cooperation in Thoracic Surgery was successfully held in Beijing. The panel for the meeting include Prof. Jie He (Chairman & Host), the President of Cancer Hospital Chinese Academy of Medical Sciences and Director of National Cancer Center of China, Academician of Chinese Academcy of Sciences; Prof. Alan Sihoe (Moderator) from University of Hong Kong; Prof. Jose Luis Danguilan, Prof. Shugeng Gao, Porf. Diego Gonzalez-Rivas, Prof. Jheon Sanghoon, Prof. Ali Zamir Khan, Prof. Lee Jang-Ming, Prof. Toriaki Morikawa, Prof. Meinoshin Okumura, Prof. Punnarerk Thongcharoen and Mr. Stephen Wang.

Read More>>

Immunotherapy in non-small cell lung cancer: the clinical impact of immune response and targeting

Cancer cells interactions with their microenvironment’s immune system. APC, antigen-presenting cell; CTL, cytotoxic T lymphocyte; IDO, indoleamine 2,3-dioxygenase; MDSC, myeloid-derived suppressor cell; PNT, peroxynitrite; TCR, T-cell receptor; MHC, major histocompatibility complex; PD-L1, programmed feath ligand 1; TGF-β, transforming growth factor-beta; VEGF, vascular endothelial growth factor.

Read More>>